Cefalexin Formulation

Hazard statements (CLP)

H334, H335, H361f, H373

Code

Statements

H334

May cause allergy or asthma symptoms or breathing difficulties if inhaled

SECTION 2: Hazards identification

Other hazards

None known

Signal word

Danger

Hazard statements

H334 May cause allergy or asthma symptoms or breathing diffi- culties if inhaled. H335 May cause respiratory irritation. H361f Suspected of damaging fertility. H373 May cause damage to organs (Kidney, Adrenal gland, Blood, Gastrointestinal tract) through prolonged or repeated

Prevention

Precautionary Statements P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe mist or vapors. P271 Use only outdoors or in a well-ventilated area. P280 Wear protective gloves, protective clothing, eye protection and face protection. P285 In case of inadequate ventilation wear respiratory protec- tion.

Response

P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a doctor if you feel unwell. P308 + P313 IF exposed or concerned: Get medical attention. P342 + P311 If experiencing respiratory symptoms: Call a doc- tor.

Storage

P405 Store locked up.

Disposal

P501 Dispose of contents and container to an approved waste disposal plant.

2.1 Classification of the substance or mixture

1910.1200) Hazards for the product as supplied Respiratory sensitization : Category 1 Reproductive toxicity : Category 2 Specific target organ toxicity : Category 3 - single exposure Specific target organ toxicity : Category 2 (Kidney, Adrenal gland, Blood, Gastrointestinal tract) - repeated exposure Other hazards